Nursing care
Beta Blockers: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Beta blocker nursing care means checking heart rate and blood pressure before every dose, holding for a heart rate under 60, and never stopping the drug abruptly because of rebound tachycardia and hypertension risk. In patients with diabetes, beta blockers blunt the tachycardia that normally signals hypoglycaemia, so blood glucose must be monitored by symptom and number, not by pulse.
Mechanism, simply
Beta blockers occupy beta-adrenergic receptors and block the effect of circulating catecholamines, adrenaline and noradrenaline. Blocking beta-1 receptors in the heart reduces heart rate, contractility and conduction velocity through the AV node, which lowers cardiac workload and myocardial oxygen demand.
Some beta blockers are cardioselective, acting mainly on beta-1 receptors in the heart, examples being metoprolol and atenolol. Non-selective agents like propranolol also block beta-2 receptors found in the lungs and blood vessels, which is why non-selective beta blockers carry a bronchospasm risk that cardioselective agents largely avoid, though selectivity can be lost at higher doses.
Indications you will see on the ward
Beta blockers are prescribed for hypertension, where reduced heart rate and contractility lower overall blood pressure. They are used in stable heart failure with reduced ejection fraction, started at a low dose and titrated slowly, since an abrupt introduction can worsen decompensated failure.
They treat angina by reducing myocardial oxygen demand, and are used post-myocardial infarction to reduce mortality and the risk of a further cardiac event. Beta blockers are also used for rate control in atrial fibrillation and other tachydysrhythmias, and for specific conditions including migraine prophylaxis, essential tremor and performance anxiety, where the mechanism is the same even though the indication looks unrelated.
Assessment before administration
Check apical pulse and blood pressure before every dose. Hold the dose and notify the prescriber if the heart rate is below 60 beats per minute or if blood pressure is below the parameters set for that patient, since beta blockade will lower both further.
Assess for a history of asthma or reactive airway disease before giving a non-selective beta blocker, since beta-2 blockade in the lungs can precipitate bronchospasm. Review for signs of decompensated heart failure, including new or worsening dyspnoea, crackles or peripheral oedema, before giving a dose in a heart failure patient, since beta blockers reduce contractility and can worsen an acutely failing heart even while they help a stable one over time.
Toxicity and the antidote
Beta blocker overdose or toxicity presents with profound bradycardia, hypotension, and in severe cases, cardiogenic shock, altered consciousness and seizures related to hypoglycaemia and reduced cerebral perfusion. The heart rate and blood pressure fall together because both effects come from the same blocked receptor.
Glucagon is the specific antidote, because it raises intracellular cyclic AMP through a receptor pathway independent of the blocked beta receptor, restoring heart rate and contractility. Atropine, intravenous fluids and vasopressors may also be used to support haemodynamics, and high-dose insulin euglycaemia therapy is used in severe cases, but glucagon remains the agent specific to this toxicity.
Interactions that matter
Combining a beta blocker with another AV node-blocking agent, particularly a non-dihydropyridine calcium channel blocker like verapamil or diltyazem, or with digoxin, compounds bradycardia and AV block risk. These combinations are used deliberately in some patients, but they need closer rate and rhythm monitoring than either drug alone.
In patients with diabetes, beta blockers blunt the adrenergic response to hypoglycaemia, tachycardia, tremor and palpitations, so the patient may not get the usual warning signs that blood sugar is falling. Diaphoresis is less affected and can remain a useful sign, but glucose monitoring by number becomes more important than relying on symptoms alone. NSAIDs can reduce the antihypertensive effect of beta blockers, and abrupt withdrawal of clonidine in a patient also on a beta blocker can cause a dangerous hypertensive rebound.
What the patient must be told
Tell the patient never to stop a beta blocker abruptly, even if they feel well or have run out of tablets, and to contact their prescriber rather than skip doses for an extended period. Abrupt discontinuation can cause rebound tachycardia, hypertension and, in patients with coronary disease, can precipitate angina or myocardial infarction.
Instruct the patient to check their pulse before each dose if advised to and to hold the dose and call their provider if it falls below the threshold given. Warn that dizziness on standing is common as the body adjusts, and to rise slowly from sitting or lying. For patients with diabetes, explain specifically that the usual warning signs of low blood sugar, a racing heart and trembling, may be reduced or absent on this medication, and that they should monitor blood glucose more closely and learn to recognise sweating and confusion as alternative warning signs.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our cardiovascular practice questions are the closest set to what this page covers.
Common questions
At what heart rate should a beta blocker be held?
Hold the dose and notify the prescriber for a heart rate below 60 beats per minute in an adult, and check the specific parameters ordered for that patient, since some prescribers set a different threshold.
Why can't beta blockers be stopped suddenly?
Chronic beta blockade upregulates beta receptor sensitivity, and abrupt withdrawal leaves those receptors exposed to normal catecholamine levels, causing rebound tachycardia and hypertension. In a patient with coronary artery disease this can trigger angina or a myocardial infarction, so the dose must always be tapered.
Why are beta blockers risky for a patient with diabetes?
Beta blockers blunt the adrenergic symptoms of hypoglycaemia, tachycardia, tremor and palpitations, that a patient normally relies on to recognise low blood sugar early. Sweating tends to remain, but blood glucose should be monitored by number rather than by symptom alone.
What is the antidote for beta blocker toxicity?
Glucagon is the specific antidote, restoring heart rate and contractility through a pathway that bypasses the blocked beta receptor. Atropine, fluids, vasopressors and high-dose insulin euglycaemia therapy support severe cases but do not replace glucagon as the specific agent.
Can a non-selective beta blocker be given to a patient with asthma?
It should be used with caution or avoided. Non-selective beta blockers also block beta-2 receptors in the lungs, which can precipitate bronchospasm, so a cardioselective agent is generally preferred in patients with reactive airway disease.
More on cardiovascular
Guides on this